ACCELERATOR CORP.

Accelerator Corporation is a venture capital firm specializing in incubation, early stage, emerging growth and start-up investments. It does not participate in further rounds of financing. The firm prefers to invest in biotechnology companies. It seeks to invest up to $2 million in a company. The firm typically holds its investments for a period of 12 months to 24 months. Accelerator Corporation was founded in 2003 and is based in Seattle, Washington. Accelerator Corporation, founded in 2003,... is a vehicle for disciplined and efficient investment in and management of emerging biotechnology opportunities. Located in Seattle, Washington, the company identifies, evaluates, finances, and manages ground breaking emerging life sciences opportunities. The company has established and built a largely proprietary array of sources of deal flow, as well as a key set of resources to bring to bear in the development of the best opportunities emerging from those sources. These key resources, provided by Accelerator and its Affiliates รขโฌโ Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, WRF Capital, Alexandria Real Estate Equities, Inc., and the Institute for Systems Biology รขโฌโ include committed investment capital, state-of-the-art facilities, world-class scientific and technical expertise and support, and experienced start-up management. This panel of Accelerator participants will discuss the success of their business model and provide practical expertise for the next generation of biotech incubators. In the past five years, nine companies have been invested in through Accelerator. Three have emerged and raised follow on financings of more than $114 million. Four remain under management at Accelerator, having raised between them $11.3 million in initial Accelerator-based investments. In all, Accelerator companies have raised in excess of $143.5 million in initial and follow-on financings. Accelerator investors have committed an additional $22.5 million to enable Accelerator to continue to identify, capitalize, and develop the next-generation of exciting emerging biotechnologies. Accelerator Corporation relies upon a unique set of sources to fill a world-class pipeline of deal flow and has established and utilized a now proven array of resources to identify, evaluate, capitalize and manage emerging biotechnology companies. Accelerator provides this unprecedented collection of resources via a partnership between top-tiered investors, dedicated management, and a world-class research institute. These groups have come together because they recognize the potential of biotechnology both as an investment opportunity and as a critical component of the rapidly evolving future of medicine and healthcare. Moreover, these individuals and organizations have extensive experience in the difficult, complex and costly process of transforming an exciting laboratory discovery into a commercial product. By providing their expertise with companies in the Accelerator portfolio, these industry leaders provide critical knowledge and resources that can help to streamline the development and accelerate the commercialization of novel technologies. Accelerator, through the global activities of its affiliates, has access to exciting new technologies and commercial opportunities developed at leading research institutions, universities and biotechnology companies around the world. This enables Accelerator to select only the most compelling investments from a deep pool of promising opportunities.
ACCELERATOR CORP.
Industry:
Banking Finance Venture Capital
Founded:
2003-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50.5 M USD
Technology used in webpage:
SPF IPv6 Google Maps Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS GFI Integra Telecom
Similar Organizations
Greenoaks Capital
Greenoaks is a global investment firm specializing in technology companies.
ImpactAlpha
ImpactAlpha offers investment news for a sustainable edge.
Mithril Capital Management
Mithril is a global technology investment firm investing in the technology, macroeconomics and finance sectors.
Current Advisors List
Current Employees Featured
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Accelerator Corp.
OVP Venture Partners
OVP Venture Partners investment in Series C - Accelerator Corp.
Washington Research Foundation
Washington Research Foundation investment in Series C - Accelerator Corp.
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series C - Accelerator Corp.
Amgen Ventures
Amgen Ventures investment in Series C - Accelerator Corp.
Versant Ventures
Versant Ventures investment in Venture Round - Accelerator Corp.
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Accelerator Corp.
MPM Capital
MPM Capital investment in Venture Round - Accelerator Corp.
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Venture Round - Accelerator Corp.
OVP Venture Partners
OVP Venture Partners investment in Venture Round - Accelerator Corp.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-07-25 | Rodeo Therapeutics | Accelerator Corp. investment in Series A - Rodeo Therapeutics | 5.9 M USD |
2016-12-12 | ApoGen Biotechnologies | Accelerator Corp. investment in Series A - ApoGen Biotechnologies | 7 M USD |
2013-05-13 | NanoString Technologies | Accelerator Corp. investment in Venture Round - NanoString Technologies | 150 K USD |
2011-08-02 | Oncofactor | Accelerator Corp. investment in Series A - Oncofactor | 2.1 M USD |
More informations about "Accelerator Corp."
Accelerator โ Venture Capital Reimagined
We catalyze the development and commercialization of breakthrough biotechnology innovations. We serve as trusted partners and deliver a complete toolkit to enhance the odds of success for โฆSee details»
Accelerator Corporation Completes $62.8 Million Oversubscribed ...
Sep 29, 2015 Accelerator Corporation, established in 2003 with operations in Seattle and New York City, is a biotechnology investment and management company. Formed by a syndicate โฆSee details»
Particle Accelerator Corporation
Particle Accelerator Corp. was started in 1991 by the principal inventors, designers and operational experts of the first proton therapy accelerator: the Loma Linda University Proton โฆSee details»
Accelerator - opps.ai
Accelerator Venture Capital Founded in 2003 in Seattle, Washington, Accelerator Corporation is a vehicle for capital-efficient investment in and management of emerging biotechnology โฆSee details»
Accelerator | IT History Society
Accelerator is a biotechnology investment and management company.Accelerator Corporation is a venture capital firm specializing in incubation, early stage, emerging growth and start-up โฆSee details»
Accelerator Corporation
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily โฆSee details»
Accelerator Corp. - Funding, Financials, Valuation & Investors
Accelerator is a biotechnology investment and management company.in funding over 4 rounds. Their latest funding was raised on Aug 3, 2007 from a Series C round. Accelerator Corp. is โฆSee details»
List of designated organizations: Immigrate with a start-up visa
Jun 25, 2025 Apply for a start-up visa You need support from at least 1 of the organizations below to apply for a start-up visa. Check the organizationโs website to see how you can get โฆSee details»
Alice Chen | Directory | Kauffman Fellows
Alice Chen is the Principal at Accelerator Corporation, a venture-backed investment vehicle based in Seattle, Washington for identifying, evaluating, financing, and managing innovative life โฆSee details»
Accelerator Corp raises $51.1 mln for fourth fund
Jul 29, 2014 SEATTLE AND NEW YORK CITY, July 29, 2014 โ Accelerator Corporation, a leading life science investment vehicle for disciplined and efficient investment in emerging โฆSee details»
Accelerator Corporation Expands Operations with New Research ...
Oct 20, 2016 Accelerator Corporation, established in 2003 in Seattle, is a biotechnology investment and management company with operations in Seattle and New York City. Formed โฆSee details»
Accelerator Corporation Secures $51.1 Million to Support โฆ
Jul 29, 2014 Accelerator Corporation, established in 2003 with operations in Seattle and New York City, is a biotechnology investment and management company. Formed by a syndicate โฆSee details»
Canadian Startup Accelerators | L-SPARK
Our startup accelerators offer mentorship and exclusive access to top investors, expert advisors, talent and prospective partners and customers.See details»
NGIF
NGIF Capital and NGIF Accelerator disclaim any liability for the reliability or completeness of third-party environmental performance claims and metrics, emissions performance statements, โฆSee details»
Accelerator Corp. - Investments, Portfolio & Company Exits
Accelerator is a biotechnology investment and management company.See details»
Accelerator Corp. - Financial Details - Crunchbase
Accelerator is a biotechnology investment and management company.How much funding has this organization raised over time? Show Announced Date Transaction Name Number of Investors โฆSee details»
accelerator-program | Mitsubishi Corporation (Americas)
Mitsubishi Corporation (Americas) is a wholly owned subsidiary of Mitsubishi Corporation - Mitsubishi Corporation is a global integrated business enterprise that develops and operates โฆSee details»
Quanterix Accelerator Laboratory Awarded Rigorous New York โฆ
6 hours ago BILLERICA, Mass., August 21, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today โฆSee details»
Accelerator Corp. - Profiles & Contacts - Crunchbase
Accelerator is a biotechnology investment and management company.See details»
Nordicus Partners Corp SEC 10-Q Report โ TradingView News
2 days ago Nordicus Partners Corporation, a business accelerator and holding company for Nordic life sciences companies entering the U.S. market, has released its Form 10-Q report for โฆSee details»